SCHEMBL407440

SCHEMBL407440

CC([C]=O)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3026230 0.75
SCHEMBL14954819 0.75
SCHEMBL3034741 0.75
SCHEMBL1268151 0.75
SCHEMBL3106766 0.73
SCHEMBL3021890 0.73
SCHEMBL42915 0.72
SCHEMBL667574 0.72
SCHEMBL4067490 0.72
SCHEMBL1040949 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929821-B derivatized polyamino acids CMC材料有限责任公司 2023-12-19 CN claimed
CN-117122721-A Sponge 贵州省农作物品种资源研究所 2023-11-28 CN claimed
US-20230139922-A1 BACITRACIN-ALGINATE OLIGOMER CONJUGATES ALGIPHARMA AS (NO) 2023-05-04 US claimed
EP-4087904-A1 DERIVATIZED POLYAMINO ACIDS CMC Materials, Inc. (US) 2022-11-16 EP claimed
CN-114929821-A Derivatized polyamino acids CMC材料股份有限公司 2022-08-19 CN claimed
CN-110643032-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2022-01-28 CN claimed
WO-2021141741-A1 DERIVATIZED POLYAMINO ACIDS CMC MATERIALS, INC. (US) 2021-07-15 WO claimed
US-20210206920-A1 DERIVATIZED POLYAMINO ACIDS CMC MATERIALS LLC 2021-07-08 US claimed
WO-2021116712-A1 FUNCTIONALISED MICROBUBBLE MEDIATED CELL TAGGING OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2021-06-17 WO claimed
US-10920265-B2 Compounds and methods for detection of enzymes that remove methyl succinyl groups from epsilon-amino lysine moieties ENZO LIFE SCIENCES, INC. (US) 2021-02-16 US claimed
WO-2008115281-A2 COMPOUNDS FOR TREATING VIRAL INFECTIONS MYRIAD GENETICS, INC. (US) 2008-09-25 WO claimed
US-20080207573-A1 COMPOUNDS FOR TREATING VIRAL INFECTIONS MYRIAD GENETICS, INCORPORATED (US) 2008-08-28 US claimed
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
EP-1828223-A2 NOVEL BETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF Panacos Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
US-20060205697-A1 Novel betulin derivatives, preparation thereof and use thereof MYREXIS, INC. 2006-09-14 US claimed
WO-2006053255-A2 NOVEL BETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF PANACOS PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed
US-20020142955-A1 Enzyme-cleavable prodrug compounds E. R. SQUIBB & SONS, L.L.C. 2002-10-03 US claimed
EP-1144011-A2 PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF Coulter Pharmaceutical, Inc. (US) 2001-10-17 EP claimed
WO-2000033888-A9 PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF COULTER PHARM INC (US) 2001-05-10 WO claimed
WO-2000033888-A2 PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF COULTER PHARMACEUTICAL, INC. (US) 2000-06-15 WO claimed